{
     "PMID": "1372673",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19920428",
     "LR": "20151119",
     "IS": "0024-3205 (Print) 0024-3205 (Linking)",
     "VI": "50",
     "IP": "14",
     "DP": "1992",
     "TI": "Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study.",
     "PG": "995-9",
     "AB": "Pretreatment of rats with the noradrenergic neurotoxin DSP-4 selectively reduced regional levels of noradrenaline in the brain by more than 75%, and decreased the concentration of endogenous DA in microdialysates of the caudate nucleus and nucleus accumbens by 52% and 28%, respectively. Results support the hypothesis that central noradrenergic mechanisms facilitate nigrostriatal and mesolimbic dopamine transmission in vivo.",
     "FAU": [
          "Lategan, A J",
          "Marien, M R",
          "Colpaert, F C"
     ],
     "AU": [
          "Lategan AJ",
          "Marien MR",
          "Colpaert FC"
     ],
     "AD": "Neurobiology Division, FONDAX-Groupe de Recherche SERVIER, Puteaux, France.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "PL": "Netherlands",
     "TA": "Life Sci",
     "JT": "Life sciences",
     "JID": "0375521",
     "RN": [
          "0 (Benzylamines)",
          "0 (Sympathomimetics)",
          "102-32-9 (3,4-Dihydroxyphenylacetic Acid)",
          "333DO1RDJY (Serotonin)",
          "54-16-0 (Hydroxyindoleacetic Acid)",
          "PQ1P7JP5C1 (DSP 4)",
          "VTD58H1Z2X (Dopamine)",
          "X4W3ENH1CV (Norepinephrine)"
     ],
     "SB": "IM",
     "MH": [
          "3,4-Dihydroxyphenylacetic Acid/metabolism",
          "Animals",
          "Benzylamines/*pharmacology",
          "Brain/drug effects/*metabolism",
          "Caudate Nucleus/drug effects/metabolism",
          "Cerebellum/drug effects/metabolism",
          "Cerebral Cortex/drug effects/metabolism",
          "Corpus Striatum/drug effects/*metabolism",
          "Dialysis/methods",
          "Dopamine/*metabolism",
          "Hippocampus/drug effects/metabolism",
          "Hydroxyindoleacetic Acid/metabolism",
          "Limbic System/drug effects/*metabolism",
          "Norepinephrine/*metabolism",
          "Nucleus Accumbens/drug effects/metabolism",
          "Organ Specificity",
          "Rats",
          "Rats, Inbred Strains",
          "Reference Values",
          "Serotonin/metabolism",
          "Substantia Nigra/drug effects/*metabolism",
          "Sympathomimetics/pharmacology"
     ],
     "EDAT": "1992/01/01 00:00",
     "MHDA": "1992/01/01 00:01",
     "CRDT": [
          "1992/01/01 00:00"
     ],
     "PHST": [
          "1992/01/01 00:00 [pubmed]",
          "1992/01/01 00:01 [medline]",
          "1992/01/01 00:00 [entrez]"
     ],
     "PST": "ppublish",
     "SO": "Life Sci. 1992;50(14):995-9.",
     "term": "hippocampus"
}